In Brief: Haemonetics
This article was originally published in The Gray Sheet
Executive Summary
Haemonetics: Receives FDA 510(k) clearance for its apheresis red cell collection devices for "automated, simultaneous collection of one unit of red blood cells and two units of plasma." The firm also announces the formation of Haemonetics Plasma Products Services, to be based in Lille, France, "to provide assistance, concrete expertise and partnership in the various steps of the continuous process from the collection of blood plasma through to its conversion into fractioned and purified plasma products"...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.